MO a HU CD16, FC gamma receptor III/fitc, clone DJ130C
Ended Purchase Order Awarded
- Contract number
- HHSN261201700025PC
- Awardee
-
Dako North America, Inc. UEI DQYMZENZQXM7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,445
Award facts
- Contract value 100% obligated
- $6,445.00 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN261201700025PC?
HHSN261201700025PC was awarded to Dako North America, Inc. by National Cancer Institute (National Institutes of Health) on November 9, 2016.
How much is contract HHSN261201700025PC worth?
The government has obligated $6,445 on HHSN261201700025PC.
Was contract HHSN261201700025PC competed?
The extent of competition for HHSN261201700025PC was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award